Data / Form D filings / GRADALIS, INC.
GRADALIS, INC.: Form D filings
GRADALIS, INC., a biotechnology company in Carrollton, TX, filed 2 Form D notices with the SEC between 2018 and 2025. The latest, on June 12, 2025, reports $12.7 million sold of a $30 million offering to 24 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2545 Golden Bear Drive, Suite 110, Carrollton, TX, 75006
- Phone
- (214) 442-8100
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1457915
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | New notice | $30,000,000 | $12,725,000 | $17,275,000 | 24 | Jun 5, 2025 | sec.gov |
| Apr 2, 2018 | New notice | $55,000,000 | $43,936,167 | $11,063,833 | 36 | Mar 16, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John P. Nemunaitis | Executive Officer, Director | |
| Harry R. Jacobson | Director | |
| Joe C. Cunningham | Director | |
| Joseph F. Berry | Director | |
| Robert P. Landin | Director | |
| David M. Shanahan | Executive Officer, Director | |
| Scott C. Seaman | Director | |
| Mark C. Early | Executive Officer |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Jun 9, 2025 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what GRADALIS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.